1. Home
  2. LGIH vs SUPN Comparison

LGIH vs SUPN Comparison

Compare LGIH & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGIH
  • SUPN
  • Stock Information
  • Founded
  • LGIH 2003
  • SUPN 2005
  • Country
  • LGIH United States
  • SUPN United States
  • Employees
  • LGIH N/A
  • SUPN N/A
  • Industry
  • LGIH Homebuilding
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • LGIH Consumer Discretionary
  • SUPN Health Care
  • Exchange
  • LGIH Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • LGIH 2.3B
  • SUPN 2.0B
  • IPO Year
  • LGIH 2013
  • SUPN 2012
  • Fundamental
  • Price
  • LGIH $98.00
  • SUPN $36.38
  • Analyst Decision
  • LGIH Hold
  • SUPN Hold
  • Analyst Count
  • LGIH 5
  • SUPN 1
  • Target Price
  • LGIH $122.40
  • SUPN $36.00
  • AVG Volume (30 Days)
  • LGIH 174.3K
  • SUPN 285.1K
  • Earning Date
  • LGIH 11-05-2024
  • SUPN 11-04-2024
  • Dividend Yield
  • LGIH N/A
  • SUPN N/A
  • EPS Growth
  • LGIH 9.16
  • SUPN 130.79
  • EPS
  • LGIH 8.36
  • SUPN 1.07
  • Revenue
  • LGIH $2,253,616,000.00
  • SUPN $651,972,000.00
  • Revenue This Year
  • LGIH N/A
  • SUPN $7.82
  • Revenue Next Year
  • LGIH $22.02
  • SUPN N/A
  • P/E Ratio
  • LGIH $11.70
  • SUPN $34.11
  • Revenue Growth
  • LGIH 0.68
  • SUPN 6.79
  • 52 Week Low
  • LGIH $84.00
  • SUPN $25.53
  • 52 Week High
  • LGIH $136.89
  • SUPN $39.37
  • Technical
  • Relative Strength Index (RSI)
  • LGIH 33.09
  • SUPN 48.87
  • Support Level
  • LGIH $98.00
  • SUPN $35.68
  • Resistance Level
  • LGIH $101.52
  • SUPN $37.35
  • Average True Range (ATR)
  • LGIH 3.18
  • SUPN 1.01
  • MACD
  • LGIH -1.20
  • SUPN -0.18
  • Stochastic Oscillator
  • LGIH 1.29
  • SUPN 21.65

About LGIH LGI Homes Inc.

LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. They have seven operating segments ( Central, Midwest, Southeast, Mid-Atlantic, Northwest, West and Florida divisions) that it aggregates into five qualifying reportable segment. Majority of the revenue is generated from Central division segment.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: